Valuation : Vista Pharmaceuticals Limited

Market Cap 38Cr 39.78L 34.23L 32.12L 29.39L 54.85L 55.29L 3.8Cr 1.48Cr 19Cr 1.49Cr 1.46Cr 62Cr P/E 2024
-10.3x
P/E 2025 -13.6x
Enterprise Value 44Cr 46.84L 40.3L 37.82L 34.6L 64.58L 65.1L 4.47Cr 1.74Cr 23Cr 1.76Cr 1.72Cr 73Cr EV / Sales 2024
7.63x
EV / Sales 2025 8.85x
Free-Float
22.51%
Yield 2024 *
-
Yield 2025 -
1 day+0.64%
1 week-0.95%
Current month+0.16%
1 month-5.56%
3 months-18.65%
6 months+4.67%
Current year-22.85%
1 week 5.8
Extreme 5.8
6.46
1 month 5.8
Extreme 5.8
7.28
Current year 5.71
Extreme 5.71
8.87
1 year 5.71
Extreme 5.71
10.75
3 years 5.71
Extreme 5.71
19.7
5 years 5.71
Extreme 5.71
19.7
10 years 4.51
Extreme 4.51
56.15
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Compliance Officer - 10/02/2024
Director TitleAgeSince
Chairman 76 02/01/2014
Director/Board Member 87 16/06/1993
Director/Board Member 76 02/02/2010
Change 5-day change 1-year change 3-year change Capi.($)
+0.64%-0.95%-35.06%-57.88% 40.63L
-0.89%-1.09%+20.02%+71.25% 4.86TCr
-1.72%-1.15%+47.28%+115.51% 4.13TCr
-2.01%-5.96%+10.68%+80.50% 1.21TCr
-0.70%-2.70%-12.22%+11.80% 1.19TCr
+0.57%-0.56%+26.56%+153.11% 914.92Cr
-0.70%-4.79%+22.05%+42.55% 748.61Cr
-0.89%-3.09%+22.42%+220.05% 734.08Cr
-1.67%-0.35%+41.04%-12.04% 752.04Cr
+0.03%-2.72%-42.28%+14.39% 519.04Cr
Average -0.73%-0.54%+10.05%+63.93% 1.51TCr
Weighted average by Cap. -1.10%-0.43%+23.72%+84.11%

Financials

2024 2025
Net sales 10Cr 10.88L 9L 9L 8L 15.01L 15.12L 1.04Cr 40.48L 5.26Cr 40.87L 39.98L 17Cr 10Cr 10.66L 9L 9L 8L 14.69L 14.81L 1.02Cr 39.64L 5.15Cr 40.02L 39.15L 17Cr
Net income -4.51Cr -5L -4L -4L -4L -7L -7L -45.59L -17.75L -2.31Cr -17.92L -17.53L -7.43Cr -4.65Cr -5L -4L -4L -4L -7L -7L -46.97L -18.29L -2.38Cr -18.47L -18.06L -7.65Cr
Net Debt 7.87Cr 8L 7L 7L 6L 11.48L 11.57L 79.52L 30.97L 4.02Cr 31.26L 30.58L 13Cr 6.67Cr 7L 6L 6L 5L 10L 10L 67.41L 26.25L 3.41Cr 26.5L 25.92L 11Cr
Logo Vista Pharmaceuticals Limited
Vista Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical products. The Company offers over the counter and prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company has its United States Food and Drug Administration (USFDA) approved manufacturing facility in India and its marketing and distribution center in United States. Its products include tablet dosage forms and capsule dosage forms. The Company's tablet dosage forms in United States market include sulfamethoxazole & trimethoprim (400/80 mg) and acetaminophen (500 mg) film coated. The Company's tablet dosage forms in Non-United States market include aspirin (300, 325 & 500 mg), atenolol (50 & 100 mg), cotrimoxazole (480 mg), captopril (25 & 50 mg) and frusemide (40 mg). Its capsule dosage forms in Non-United States market include indomethacin (25 mg), piroxicam (10 & 20 mg) and nifedipine (10 mg).
Employees
30
Date Price Change Volume
04/26/04 6.280 +0.64% 3,604
03/26/03 ₹6.240 +2.46% 2,240
02/26/02 ₹6.090 +1.50% 4,905
01/26/01 ₹6.000 -4.31% 5,939
31/26/31 ₹6.270 -1.10% 9,143
  1. Stock Market
  2. Stocks
  3. VISTAPH6 Stock